ICOS and ICOS ligand: expression patterns and outcomes in oncology patients by Mina Nikanjam, Shumei Kato, Daisuke Nishizaki, Donald A. Barkauskas, Sarabjot Pabla, Mary K. Nesline, Jeffrey M. Conroy, Aung Naing, Razelle Kurzrock

Get full text

4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists by Yuji Uehara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K. Nesline, Sarabjot Pabla, Jeffrey M. Conroy, Paul DePietro, Heidi Ko, Jason K. Sicklick, Razelle Kurzrock

Get full text

RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancer by Kyle C. Strickland, Zachary D. Wallen, Heidi C. Ko, Michelle F. Green, Alicia Dillard, Sarabjot Pabla, Stephanie Hastings, Alison Roos, Taylor J. Jensen, Marcia Eisenberg, Brian J. Caveney, Shakti Ramkissoon, Eric A. Severson, Rebecca A. Previs

Get full text

RNA hybrid-capture next-generation sequencing has high sensitivity in identifying known and less characterized oncogenic and likely oncogenic NTRK fusions in a real-world standard-... by Zachary D. Wallen, Marni Tierno, Erica Schnettler, Alison Roos, Michelle Green, Kobina Amoah, Rebecca A. Previs, Stephanie Hastings, Sarabjot Pabla, Taylor J. Jensen, Brian Caveney, Marcia Eisenberg, Pratheesh Sathyan, Shakti H. Ramkissoon, Shakti H. Ramkissoon, Eric A. Severson

Get full text